1 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
| 1 | 33008427 | The MUK eight protocol: a randomised phase II trial of cyclophosphamide and dexamethasone in combination with ixazomib, in relapsed or refractory multiple myeloma (RRMM) patients who have relapsed after treatment with thalidomide, lenalidomide and a proteasome inhibitor. | 2020 Oct 2 | 1 |